2 options
Competitive Problems in the Drug Industry : Psychotropic Drugs.
- Format:
- Book
- Government document
- Author/Creator:
- Library of Congress. Congressional Research Service.
- Language:
- English
- Subjects (All):
- Advertising.
- Consumer protection.
- Drug abuse.
- Physical Description:
- 1 online resource (114 pages) : digital, PDF file
- monochrome
- Place of Publication:
- [Place of publication not identified] : [publisher not identified], 1979-1980.
- System Details:
- System requirements: PDF reader software.
- text file
- Summary:
- Appendices (pages 39-112) include lists of currently available psychotropic and OTC drugs (pages 46-52) and "Over-the-Counter Nighttime Sleep-Aid and Stimulant Products," FDA Tentative Final Orders, Fed Register, June 13, 1978 (pages 53-112).
- CRS report, prepared by consultant Stephanie Forbes, summarizing, analyzing, and updating 1969-77 Subcom on Monopoly and Anticompetitive Activities hearings (topical index, pages 41-45) on issues surrounding public use of prescription and over-the-counter (OTC) drugs. Examines health hazards and benefits of the so-called mood drugs, societal and public policy implications and responsibilities, the effect of advertising and promotion on drug use, and related FCC, FTC, and FDA initiatives.
- Notes:
- CRS Report.
- Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed June 2010). Reuse except for individual research requires license from ProQuest, LLC.
- Other Format:
- Microfiche version: Library of Congress. Congressional Research Service. Competitive Problems in the Drug Industry:. 79-S722-14
- Access Restriction:
- Restricted for use by site license.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.